Influenza

Adequate Vaccine Coverage Trumps Oseltamivir Prophylaxis In Outbreaks

Published in Vaccine Weekly, April 18th, 2001

by N.R. Saltmarsh, staff medical writer - The antiviral medication oseltamivir may be useful for controlling outbreaks of influenza B, but vaccination of patients and staff in long-term care facilities remains the best way to address influenza and influenza-like illness (ILI).

Until further studies are conducted to determine its cost-effectiveness and to standardize protocols, oseltamivir's widespread use for influenza B cannot yet be justified, say researchers working in British Columbia.

R. Parker and colleagues described an outbreak of ILI and influenza B in a long-term care facility in which oseltamivir prophylaxis kept the attack rate at 10%,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2001-04-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry